A multiantigenic Orf virus-based vaccine efficiently protects hamsters and nonhuman primates against SARS-CoV-2. [PDF]
Reguzova A +18 more
europepmc +1 more source
First-in-Human Phase I Trial to Assess the Safety and Immunogenicity of an Orf Virus-Based COVID-19 Vaccine Booster. [PDF]
Esen M +19 more
europepmc +1 more source
Efficient and scalable clarification of Orf virus from HEK suspension for vaccine development. [PDF]
Pagallies F +4 more
europepmc +1 more source
Retrospective research: identifying and conducting phylogenetic analyses on four Orf virus strains isolated in Yunnan province between 2021 and 2023-revealing their significance and characteristic features. [PDF]
Xie J +5 more
europepmc +1 more source
Finger nodules with a papulovesicular hands and feet eruption: a complicated human Orf virus infection. [PDF]
Salvi M +6 more
europepmc +1 more source
The Global Evolutionary History of Orf Virus in Sheep and Goats Revealed by Whole Genomes Data. [PDF]
Coradduzza E +17 more
europepmc +1 more source
Immunogenicity of chimeric hemagglutinins delivered by an orf virus vector platform against swine influenza virus. [PDF]
do Nascimento GM +3 more
europepmc +1 more source
Genistein is effective in inhibiting Orf virus infection in vitro by targeting viral RNA polymerase subunit RPO30 protein. [PDF]
Lv P +14 more
europepmc +1 more source
A novel orf virus vector-based COVID-19 booster vaccine shows cross-neutralizing activity in the absence of anti-vector neutralizing immunity. [PDF]
Klinkardt U +15 more
europepmc +1 more source

